Novel clinical manifestations and treatment of hereditary apoA-I amyloidosis: when a good protein turns bad.
Where this comes from
- Record sourced from PubMed, PMID 32571494.
- Also identified by DOI 10.1016/j.kint.2020.03.030 and PMC identifier 8423090.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Amyloidoses are life-threatening diseases caused by the deposition of various proteins including apolipoprotein A-I, the major protein of plasma high-density lipoprotein. Timely diagnostics of amyloidoses are crucial for their treatment. Colombat et al. reported novel aspects of the hereditary apolipoprotein A-I amyloidosis, including its unexpected clinical presentation and genetic origins, as well as life- and vision-saving hepatorenal transplantation. This study improves the diagnostics of apolipoprotein A-I amyloidosis, optimizes its treatment, and expands our understanding of the molecular basis of this multipronged disease.
Medical subject headings
- Amyloidosis
- Amyloidosis, Familial